<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01577446</url>
  </required_header>
  <id_info>
    <org_study_id>LM-002</org_study_id>
    <nct_id>NCT01577446</nct_id>
  </id_info>
  <brief_title>Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)</brief_title>
  <acronym>NARROW-CRT</acronym>
  <official_title>Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Santa Maria di Loreto Mare</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Santa Maria di Loreto Mare</source>
  <brief_summary>
    <textblock>
      Current recommendations require a QRS duration of ≥120ms as a condition for prescribing
      cardiac resynchronization therapy (CRT). This study was designed to test the hypothesis that
      patients with heart failure of ischemic origin, current indications for defibrillator
      implantation and QRS &lt;120ms may benefit from CRT in the presence of marked mechanical
      dyssynchrony.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>heart failure clinical composite score</measure>
    <time_frame>12 months</time_frame>
    <description>Patients are classified according to a score, which assigns subjects to one of three response groups — improved, worsened, or unchanged. Patients are judged to be worsened if they died or were hospitalized because of worsening heart failure (at any time during the 12 months), or demonstrated worsening in NYHA functional class at their 12-month visit. Patients are judged to be improved if they had not worsened and had demonstrated improvement in NYHA functional class at 12 months. Patients who are not worsened or improved are classified as unchanged.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to the first heart failure hospitalization or death</measure>
    <time_frame>up to 30 months</time_frame>
    <description>Kaplan-Meier analysis is used to analyze time to death or first heart failure hospitalization</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Heart Failure, Systolic</condition>
  <arm_group>
    <arm_group_label>CRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The CRT group undergoes implantation of a CRT defibrillator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no-CRT</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The no-CRT group receives a dual-chamber defibrillator</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardiac resynchronization therapy</intervention_name>
    <description>Implantation of a CRT defibrillator with a standard right atrial, right ventricular defibrillator and left ventricular leads</description>
    <arm_group_label>CRT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  NHYA class II-III heart failure

          -  ischemic cardiomyopathy

          -  ejection fraction of 35% or less

          -  QRS interval of 120ms or less

          -  evidence of mechanical dyssynchrony as measured on echocardiography

        Exclusion Criteria:

          -  conventional indication for cardiac pacing

          -  persistent atrial fibrillation

          -  life expectancy lower than 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmine Muto, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ospedale Santa Maria di Loreto Mare</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ospedale Santa Maria di Loreto Mare</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2012</study_first_submitted>
  <study_first_submitted_qc>April 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 13, 2012</study_first_posted>
  <last_update_submitted>October 15, 2016</last_update_submitted>
  <last_update_submitted_qc>October 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Santa Maria di Loreto Mare</investigator_affiliation>
    <investigator_full_name>Carmine Muto</investigator_full_name>
    <investigator_title>Electrophysiology and Pacing Unit Director</investigator_title>
  </responsible_party>
  <keyword>CRT</keyword>
  <keyword>heart failure</keyword>
  <keyword>narrow QRS</keyword>
  <keyword>dyssynchrony</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

